Figure 3.

Frequency of incident and recurrent infections from years 1-3 post-transplant, by intensity of desensitization.

ILDKT recipients were more likely to develop both incident and recurrent infections, particularly those who were highly desensitized. In the second year post-KT, 23.2% of recipients developed an infection; of these, 66.4% were recurrent infections (none=12.7%, low=19.1%, moderate=13.5%, high=22.3%). In the third year post-KT, 16.6% of recipients developed an infection; of these, 84.8% were recurrent infections (none=12.7%, low=10.6%, moderate=14.9%, high=19.1%).